Navellier & Associates’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
DKCM
Navellier & Associates's QGEN Position: Q2 2021 in Review
Navellier & Associates sold out of Qiagen (QGEN) in Q2 2021, closing a stake of 8,947 shares — an estimated $462K sold.
Navellier & Associates first reported a position in QGEN in Q4 2020 and held it in 2 quarters. The position peaked at $473K in Q4 2020. 257 funds tracked by Wall St. Rank hold QGEN as of Q2 2021.
- Navellier & Associates reported no remaining Qiagen position as of Q2 2021 after selling out during the quarter.
- Navellier & Associates sold 8,947 Qiagen shares in Q2 2021, an estimated $462K.
- Navellier & Associates first reported a position in Qiagen in Q4 2020 and held it in 2 quarters.
- Navellier & Associates's Qiagen position peaked at $473K in Q4 2020.
- 257 funds tracked by Wall St. Rank held Qiagen as of Q2 2021.
Based on Navellier & Associates's 13F filing for Q2 2021, filed 9 Aug 2021.